Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reginald Bruskewitz

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Urology|November 2, 2019
Editorial CommentReginald Bruskewitz
Urology|February 26, 2019
EDITORIAL COMMENTDaniel Shapiro, Reginald Bruskewitz
Urologic Oncology|May 12, 2005
Long-term complications associated with the Indiana pouch urinary diversion in patients with recurrent gynecologic cancers after high-dose radiationMichael Wilkin, Greg Horwitz, Anil Seetharam, et al.
The Journal of Urology|May 6, 2004
Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trialBrian Hill, William Belville, Reginald Bruskewitz, et al.
The Journal of Urology|April 21, 2009
Variation in institutional review board responses to a standard protocol for a multicenter randomized, controlled surgical trialBrian T Helfand, Anne K Mongiu, Claus G Roehrborn, et al.
The Journal of Urology|July 28, 2011
Effects of 100 and 300 units of onabotulinum toxin A on lower urinary tract symptoms of benign prostatic hyperplasia: a phase II randomized clinical trialE David Crawford, Kathryn Hirst, John W Kusek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancerGlenn Liu, Kurt Oettel, Gregory Ripple, et al.
The Journal of Urology|February 10, 2004
Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasiaClaus G Roehrborn, Reginald Bruskewitz, J Curtis Nickel, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Urology|November 2, 2019
Editorial CommentReginald Bruskewitz
Urology|February 26, 2019
EDITORIAL COMMENTDaniel Shapiro, Reginald Bruskewitz
Urologic Oncology|May 12, 2005
Long-term complications associated with the Indiana pouch urinary diversion in patients with recurrent gynecologic cancers after high-dose radiationMichael Wilkin, Greg Horwitz, Anil Seetharam, et al.
The Journal of Urology|May 6, 2004
Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trialBrian Hill, William Belville, Reginald Bruskewitz, et al.
The Journal of Urology|April 21, 2009
Variation in institutional review board responses to a standard protocol for a multicenter randomized, controlled surgical trialBrian T Helfand, Anne K Mongiu, Claus G Roehrborn, et al.
The Journal of Urology|July 28, 2011
Effects of 100 and 300 units of onabotulinum toxin A on lower urinary tract symptoms of benign prostatic hyperplasia: a phase II randomized clinical trialE David Crawford, Kathryn Hirst, John W Kusek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancerGlenn Liu, Kurt Oettel, Gregory Ripple, et al.
The Journal of Urology|February 10, 2004
Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasiaClaus G Roehrborn, Reginald Bruskewitz, J Curtis Nickel, et al.
Pageof 1